المؤلفون: Edwards JG; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA., Yan AP; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Yim R; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA., Oni M; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., Heeney MM; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., Johnson D; Boston Children's Hospital Program for Patient Safety and Quality, Boston, Massachusetts, USA., Wong CI; Division of Hematology/Oncology, Rainbow Babies and Children's Hospital and Seidman Cancer Center, University Hospitals, Cleveland, Ohio, USA., Ilowite M; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., Archer NM; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.

المصدر: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Aug; Vol. 71 (8), pp. e31088. Date of Electronic Publication: 2024 May 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Anemia, Sickle Cell*/diagnostic imaging , Anemia, Sickle Cell*/complications , Ultrasonography, Doppler, Transcranial*/methods , Quality Improvement*, Humans ; Child ; Female ; Male ; Adolescent ; Child, Preschool ; Stroke/etiology ; Stroke/prevention & control ; Stroke/diagnostic imaging ; Mass Screening/methods ; Mass Screening/standards ; Follow-Up Studies ; Prognosis

المؤلفون: Harris EM; Department of Pediatrics, Boston Children's Hospital.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center., Oni MO; Department of Pediatrics, Boston Children's Hospital.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center., Donado C; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital., Heeney MM; Department of Pediatrics, Boston Children's Hospital.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center., Solodiuk J; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital., Greco C; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital., Archer NM; Department of Pediatrics, Boston Children's Hospital.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center.

المصدر: Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2024 Jul 01; Vol. 46 (5), pp. e290-e295. Date of Electronic Publication: 2024 May 02.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9505928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-3678 (Electronic) Linking ISSN: 10774114 NLM ISO Abbreviation: J Pediatr Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Ketorolac*/adverse effects , Ketorolac*/therapeutic use , Anemia, Sickle Cell*/complications , Anemia, Sickle Cell*/drug therapy , Acute Kidney Injury*/chemically induced , Acute Kidney Injury*/etiology , Anti-Inflammatory Agents, Non-Steroidal*/adverse effects , Acute Pain*/drug therapy , Acute Pain*/etiology, Humans ; Male ; Female ; Child ; Adolescent ; Child, Preschool ; Case-Control Studies ; Retrospective Studies ; Risk Factors

المؤلفون: Williams AR; Divisions of Pediatrics., Archer NM; Hematology, Boston Children's Hospital, Boston, Massachusetts.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.

المصدر: Pediatrics [Pediatrics] 2024 Jul 01; Vol. 154 (1).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Academy of Pediatrics Country of Publication: United States NLM ID: 0376422 Publication Model: Print Cited Medium: Internet ISSN: 1098-4275 (Electronic) Linking ISSN: 00314005 NLM ISO Abbreviation: Pediatrics Subsets: MEDLINE

مواضيع طبية MeSH: Anemia, Sickle Cell*/therapy , Anemia, Sickle Cell*/epidemiology, Humans ; Child ; Early Medical Intervention ; Health Equity ; Healthcare Disparities

المؤلفون: Oni MO; Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA 02115, USA., Brito M; H&TRC-Health & Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, 1990-092 Lisbon, Portugal., Rotman C; Medical Library, Boston Children's Hospital, Boston, MA 02115, USA., Archer NM; Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA 02115, USA.

مؤلفون مشاركون: International Hemoglobinopathy Research Network (INHERENT)

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 07; Vol. 25 (12). Date of Electronic Publication: 2024 Jun 07.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Anemia, Sickle Cell*/genetics , Anemia, Sickle Cell*/complications , Stroke*/genetics , Genome-Wide Association Study* , Genetic Predisposition to Disease*, Humans ; Genes, Modifier ; Fetal Hemoglobin/genetics ; Fetal Hemoglobin/metabolism

المؤلفون: Harris EM; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Division of Hematology, Boston Children's Hospital, Boston, Massachusetts, USA., Donado C; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Anaesthesia, Harvard Medical School, Boston, Massachusetts, USA., Archer NM; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Division of Hematology, Boston Children's Hospital, Boston, Massachusetts, USA.

المصدر: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Jan; Vol. 71 (1), pp. e30740. Date of Electronic Publication: 2023 Oct 25.

نوع المنشور: Letter

بيانات الدورية: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Ketamine*/therapeutic use , Anemia, Sickle Cell*/complications , Anemia, Sickle Cell*/drug therapy, Humans ; Child ; Pain/drug therapy ; Pain/etiology ; Analgesics/therapeutic use

المؤلفون: Archer NM; Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA.

المصدر: Blood advances [Blood Adv] 2023 Oct 10; Vol. 7 (19), pp. 5968-5969.

نوع المنشور: Editorial; Comment

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Anemia, Sickle Cell* , Malaria*, Humans ; Hydroxyurea/adverse effects

المؤلفون: Archer NM; Pediatric Hematology/Oncology Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Gnangnon B; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Center for Communicable Diseases Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Mikdar M; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Ciuculescu MF; The TransLab, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Petersen N; Pediatric Hematology/Oncology Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Staffa SJ; Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA., Duraisingh MT; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

المصدر: American journal of hematology [Am J Hematol] 2023 Oct; Vol. 98 (10), pp. 1598-1605. Date of Electronic Publication: 2023 Aug 16.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Anemia, Sickle Cell* , Plasmodium falciparum* , Malaria, Falciparum*, Humans ; Fetal Hemoglobin ; Cell Proliferation ; Erythrocytes

المؤلفون: Yan AP; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts., Archer NM; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts., Arnold D; Boston Children's Hospital, Boston, Massachusetts., Hansbury E; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts., Heeney MM; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts., Johnson D; Boston Children's Hospital Program for Patient Safety and Quality, Boston, Massachusetts., Lichtman E; Boston Children's Hospital, Boston, Massachusetts., McMullan H; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts., Morrissey L; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts., Ilowite M; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.

المصدر: Pediatrics [Pediatrics] 2023 Oct 01; Vol. 152 (4).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Academy of Pediatrics Country of Publication: United States NLM ID: 0376422 Publication Model: Print Cited Medium: Internet ISSN: 1098-4275 (Electronic) Linking ISSN: 00314005 NLM ISO Abbreviation: Pediatrics Subsets: MEDLINE

المؤلفون: De Souza DC; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.; Department of Systems Biology, Harvard Medical School, Boston, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Hebert N; French Blood Establishment (EFS), Créteil, France.; University Paris-Est-Créteil, IMRB, Laboratory of excellence LABEX, Créteil, France.; Paris-East Créteil University, Henri Mondor University Hospitals, APHP, Sickle Cell Referral Center-UMGGR, Créteil, France., Esrick EB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA., Ciuculescu MF; Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Archer NM; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA., Armant M; Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Audureau É; INSERM U955 Team CEpiA, Paris-East Créteil University, Créteil, France.; Department of Public Health, Henri Mondor University Hospitals, APHP, Créteil, France., Brendel C; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA., Di Caprio G; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.; Department of Biomedical Engineering, University of Strathclyde, Glasgow, United Kingdom., Galactéros F; University Paris-Est-Créteil, IMRB, Laboratory of excellence LABEX, Créteil, France.; Paris-East Créteil University, Henri Mondor University Hospitals, APHP, Sickle Cell Referral Center-UMGGR, Créteil, France., Liu D; Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., McCabe A; Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Morris E; Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Schonbrun E; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA., Williams D; Department of Biomedical Engineering, University of Minnesota, Minneapolis, MN, USA., Wood DK; Department of Biomedical Engineering, University of Minnesota, Minneapolis, MN, USA., Williams DA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. david.williams2@childrens.harvard.edu.; Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. david.williams2@childrens.harvard.edu.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA. david.williams2@childrens.harvard.edu., Bartolucci P; University Paris-Est-Créteil, IMRB, Laboratory of excellence LABEX, Créteil, France. pablo.bartolucci@aphp.fr.; Paris-East Créteil University, Henri Mondor University Hospitals, APHP, Sickle Cell Referral Center-UMGGR, Créteil, France. pablo.bartolucci@aphp.fr., Higgins JM; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA. higgins.john@mgh.harvard.edu.; Department of Systems Biology, Harvard Medical School, Boston, MA, USA. higgins.john@mgh.harvard.edu.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA. higgins.john@mgh.harvard.edu.

المصدر: Nature communications [Nat Commun] 2023 Sep 20; Vol. 14 (1), pp. 5850. Date of Electronic Publication: 2023 Sep 20.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Hemoglobin, Sickle* , Hydroxyurea*/pharmacology , Hydroxyurea*/therapeutic use, Adult ; Humans ; Erythrocytes ; Fetus ; Fetal Hemoglobin/genetics ; Transcription Factors

المؤلفون: Donado C; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital (C.D., J.C.S., C.D.G.), Boston, Massachusetts, USA; Department of Anaesthesia, Harvard Medical School (C.D., J.C.S., C.D.G.), Boston, Massachusetts, USA., Harris EM; Department of Pediatrics, Boston Children's Hospital (E.M.H., M.M.H., N.M.A.), Boston, Massachusetts, USA., Heeney MM; Department of Pediatrics, Boston Children's Hospital (E.M.H., M.M.H., N.M.A.), Boston, Massachusetts, USA; Division of Hematology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center (M.M.H., N.M.A.), Boston, Massachusetts, USA., Solodiuk JC; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital (C.D., J.C.S., C.D.G.), Boston, Massachusetts, USA; Department of Anaesthesia, Harvard Medical School (C.D., J.C.S., C.D.G.), Boston, Massachusetts, USA., Greco CD; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital (C.D., J.C.S., C.D.G.), Boston, Massachusetts, USA; Department of Anaesthesia, Harvard Medical School (C.D., J.C.S., C.D.G.), Boston, Massachusetts, USA., Archer NM; Department of Pediatrics, Boston Children's Hospital (E.M.H., M.M.H., N.M.A.), Boston, Massachusetts, USA; Division of Hematology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center (M.M.H., N.M.A.), Boston, Massachusetts, USA. Electronic address: natasha.archer@childrens.harvard.edu.

المصدر: Journal of pain and symptom management [J Pain Symptom Manage] 2023 May; Vol. 65 (5), pp. e409-e415. Date of Electronic Publication: 2023 Jan 11.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 8605836 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-6513 (Electronic) Linking ISSN: 08853924 NLM ISO Abbreviation: J Pain Symptom Manage Subsets: MEDLINE

مواضيع طبية MeSH: Analgesia, Patient-Controlled* , Anemia, Sickle Cell*/complications , Anemia, Sickle Cell*/drug therapy, Humans ; Child ; Adolescent ; Analgesics, Opioid/therapeutic use ; Retrospective Studies ; Pain/etiology ; Pain/complications